The cerebrospinal fluid choline levels in patients with Huntington's chorea. Negative effect of haloperidol treatment.
Lumbar cerebrospinal fluid (CSF) choline (CH) levels were measured in patients with Huntington's chorea (n = 14). This group was found not to differ significantly from normal controls (n = 13). The values for lumbar CSF Ch levels in the normal subjects were comparable with previously reported values. Of the choreic patients, seven were put on haloperidol treatment (4--6 mg daily). The CSF choline level remained unchanged with this treatment after 20 days. CSF cholinesterase activity was measured in the control and choreic group. The results were not significantly different.
D000328:Adult; D002794:Choline / Q000134:cerebrospinal fluid*; D002802:Cholinesterases / Q000134:cerebrospinal fluid; D005260:Female; D006220:Haloperidol / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006816:Huntington Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
D002802:Cholinesterases; D006220:Haloperidol; D002794:Choline